Sarah B Kavanagh is Director of Bausch Health Companies Inc.. Currently has a direct ownership of 182,012 shares of BHC, which is worth approximately $1.39 Million. The most recent transaction as insider was on May 17, 2024, when has been sold 35,360 shares (Common Shares, no par value) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 182K
0% 3M change
24.11% 12M change
Total Value Held $1.39 Million

SARAH B KAVANAGH Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 17 2024
BUY
Grant, award, or other acquisition
-
35,360 Added 16.27%
182,012 Common Shares, no par ...
May 19 2023
BUY
Grant, award, or other acquisition
-
29,205 Added 16.61%
146,652 Common Shares, no par ...
Jun 24 2022
BUY
Grant, award, or other acquisition
-
34,387 Added 22.65%
117,447 Common Shares, no par ...
Apr 30 2021
BUY
Grant, award, or other acquisition
-
7,645 Added 8.43%
83,060 Common Shares, no par ...

Also insider at

BLCO
Bausch & Lomb Corp Healthcare
SBK

Sarah B Kavanagh

Director
Bridgewater, NJ

Track Institutional and Insider Activities on BHC

Follow Bausch Health Companies Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BHC shares.

Notify only if

Insider Trading

Get notified when an Bausch Health Companies Inc. insider buys or sells BHC shares.

Notify only if

News

Receive news related to Bausch Health Companies Inc.

Track Activities on BHC